Stock Analysis

Genky DrugStores Co., Ltd. (TSE:9267) CEO Kenichi Fujinaga's holdings dropped 6.5% in value as a result of the recent pullback

Advertisement

Key Insights

Every investor in Genky DrugStores Co., Ltd. (TSE:9267) should be aware of the most powerful shareholder groups. We can see that individual insiders own the lion's share in the company with 42% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

As market cap fell to JP¥148b last week, insiders would have faced the highest losses than any other shareholder groups of the company.

In the chart below, we zoom in on the different ownership groups of Genky DrugStores.

Check out our latest analysis for Genky DrugStores

ownership-breakdown
TSE:9267 Ownership Breakdown December 5th 2025

What Does The Institutional Ownership Tell Us About Genky DrugStores?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

As you can see, institutional investors have a fair amount of stake in Genky DrugStores. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Genky DrugStores, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
TSE:9267 Earnings and Revenue Growth December 5th 2025

We note that hedge funds don't have a meaningful investment in Genky DrugStores. Looking at our data, we can see that the largest shareholder is the CEO Kenichi Fujinaga with 41% of shares outstanding. For context, the second largest shareholder holds about 9.6% of the shares outstanding, followed by an ownership of 5.3% by the third-largest shareholder.

To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There is some analyst coverage of the stock, but it could still become more well known, with time.

Insider Ownership Of Genky DrugStores

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

Our information suggests that insiders maintain a significant holding in Genky DrugStores Co., Ltd.. Insiders own JP¥62b worth of shares in the JP¥148b company. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

General Public Ownership

The general public, who are usually individual investors, hold a 24% stake in Genky DrugStores. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Private Company Ownership

It seems that Private Companies own 5.3%, of the Genky DrugStores stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For example, we've discovered 2 warning signs for Genky DrugStores that you should be aware of before investing here.

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:9267

Genky DrugStores

Engages in the management and operation of food and drug chain stores in Japan.

Solid track record with adequate balance sheet.

Advertisement

Weekly Picks

RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8696.7% undervalued
50 users have followed this narrative
6 users have commented on this narrative
16 users have liked this narrative
RO
Robbo
FID logo
Robbo on Fiducian Group ·

Fiducian: Compliance Clouds or Value Opportunity?

Fair Value:AU$122.0% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WO
WVVI logo
woodworthfund on Willamette Valley Vineyards ·

Willamette Valley Vineyards (WVVI): Not-So-Great Value

Fair Value:US$247.5% overvalued
10 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

IN
PSD logo
IncomeAssets on Pulse Seismic ·

Watch Pulse Seismic Outperform with 13.6% Revenue Growth in the Coming Years

Fair Value:CA$4.4729.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VL
GGO logo
Vladislav on Galleon Gold ·

Significantly undervalued gold explorer in Timmins, finally getting traction

Fair Value:CA$482.8% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
FU
CCP logo
FundamentallySarcastic on Credit Corp Group ·

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Fair Value:AU$12.6410.8% overvalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.5% undervalued
116 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3926.8% undervalued
957 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
AN
AnalystConsensusTarget
GOOGL logo
AnalystConsensusTarget on Alphabet ·

GOOGL: AI Platform Expansion And Cloud Demand Will Support Durable Performance Amid Competitive Pressures

Fair Value:US$323.71.9% undervalued
1342 users have followed this narrative
0 users have commented on this narrative
17 users have liked this narrative

Trending Discussion